Chronically administered risperidone did not change the number of hepatocytes in rats: A stereological and histopathological study

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 5, 2008, Pages 426-432

  Halici, Zekai ^a   Keles, Osman Nuri ^a   Unal, Deniz ^a   Albayrak, Mevlut ^a   Suleyman, Halis ^a   Cadirci, Elif ^a   Unal, Bunyami ^a   Kaplan, Suleyman ^b  

^a ATATURK UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DISSECTION; DRUG MEGADOSE; HISTOPATHOLOGY; LIVER CELL; LIVER TOXICITY; LOW DRUG DOSE; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOLOGY; TISSUE FIXATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY;

ANIMALS; ANTIPSYCHOTIC AGENTS; HEPATITIS, TOXIC; HEPATOCYTES; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, WISTAR; RISPERIDONE;

RATTUS;

EID: 42149085109     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00198.x     Document Type: Article

References (43)

1. Gerber JE, Cawthon B. Overdose and death with olanzapine: two case reports. Am J Forensic Med Pathol 2000 21 : 249 51.
2. Krebs S, Dormann H, Muth-Selbach U, Hahn EG, Brune K, Schneider HT. Risperidone-induced cholestatic hepatitis. Eur J Gastroenterol Hepatol 2001 13 : 67 9.
3. Leysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, Janssen PA. Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 1988 247 : 661 70.
4. Uchida S, Kato Y, Hirano K, Kagawa Y, Yamada S. Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine. Life Sci 2007 80 : 1635 40.
5. Minet-Ringuet J, Even PC, Valet P et al. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment. Mol Psychiatry 2007 12 : 562 71.
6. Houseknecht KL, Robertson AS, Zavadoski W, Gibbs EM, Johnson DE, Rollema H. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects. Neuropsychopharmacology 2007 32 : 289 97.
7. O'brien E, Dedova I, Duffy L, Cordwell S, Karl T, Matsumoto I. Effects of chronic risperidone treatment on the striatal protein profiles in rats. Brain Res 2006 1113 : 24 32.
8. Fachinformation. Risperdal (risperidon). Janssen-Cilag GmbH, Neuss, Germany, 1998.
9. Collaborative working group on clinical trial evaluations. Adverse effects of the atypical antipsychotics. J Clin Psychiatr 1998 12 : 17 22.
10. Benazzi F. Risperidone-induced hepatotoxicity (Case report). Pharmacopsychiatry 1998 31 : 241.
11. Fuller MA, Simon MR, Freedman L. Risperidone-associated hepatotoxicity. J Clin Psychopharmacol 1996 16 : 84 5.
12. Taira M, Hashimoto T, Takamatsu T, Maeda K. Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects. Prog Neuropsychopharmacol Biol Psychiatry 2006 30 : 1139 42.
13. Russ JC, Dehoff RT. Practical Stereology, 2nd edn, Plenum Press, New York, 1999 170 85.
14. Di Matteo V, Cacchio M, Di Giulio C, Di Giovanni G, Esposito E. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo. Pharmacol Biochem Behav 2002 71 : 607 13.
15. Chang WH, Jaw SS, Tsay L. Chronic haloperidol treatment with low doses may enhance the increase of homovanillic acid in rat brain. Eur J Pharmacol 1989 162 : 151 56.
16. Cruz-Orive LM, Gual-Arnau X. Precision of circular systematic sampling. J Microsc 2002 207 : 225 42.
17. Gundersen HJ, Jensen EB, Kieu K, Nielsen J. The efficiency of systematic sampling in stereology-reconsidered. J Microsc 1999 193 : 199 11.
18. Gardi JE, Nyengaard JR, Gundersen HJ. Using biased image analysis for improving unbiased stereological number estimation-a pilot simulation study of the smooth fractionator. J Microsc 2006 222 : 242 50.
19. Marcos R, Monteiro RA, Rocha E. Design-based stereological estimation of hepatocyte number, by combining the smooth optical fractionator and immunocytochemistry with anti-carcinoembryonicantigen polyclonal antibodies. Liver Int 2006 26 : 116 24.
20. Gundersen HJ, Bagger P, Bendtsen TF et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988 96 : 857 81.
21. Gundersen HJ. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. J Microsc 1986 143 : 3 45.
22. Gray T. Quantitation in histopathology In : Bancroft JD, Stevens A (eds). Theory and Practice of Histological Techniques. Pearson Professional Limited, New York/ Churchill Livingstone, London, 1996 641 71.
23. Sterio DC. The Unbiased estimation of number and size of arbitrary particles using the disector. J Microsc 1984 134 : 127 36.
24. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987 147 : 229 63.
25. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 1995 333 : 1118 27.
26. Zimmerman HJ, Maddrey WC. Toxic and drug-induced hepatitis. In : Schiff L, Schiff ER (eds). Diseases of the Liver. J.B. Lippincott, Philadelphia, PA, 1993 707 83.
27. Dumortier G, Cabaret W, Stamatiadis L et al. Hepatic tolerance of atypical antipsychotic drugs. Encephale 2002 28 : 542 51.
28. Radzik J, Grotthus B, Leszek J. Disorder of liver functions in a schizophrenic patient after long-term risperidone treatment - case report. Psychiatr Pol 2005 39 : 309 13.
29. Rodda KE, Drummer OH. The redistribution of selected psychiatric drugs in post-mortem cases. Forensic Sci Int 2006 164 : 235 39.
30. Haduch A, Ogorka T, Boksa J, Daniel WA. Interactions between neuroleptics and CYP2C6 in rat liver - in vitro and ex vivo study. Pharmacol Rep 2005 57 : 872 77.
31. Llinares Tello F, Hernandez Prats C, Bosacoma Ros N et al. Acute cholestatic hepatitis probably associated with risperidone. Int J Psychiatry Med 2005 35 : 199 205.
32. Belhani D, Frassati D, Megard R et al. Cardiac lesions induced by neuroleptic drugs in the rabbit. Exp Toxicol Pathol 2006 57 : 207 12.
33. Gil-Ad I, Shtaif B, Shiloh R, Weizman A. Evaluation of the neurotoxic activity of typical and atypical neuroleptics:relevance to iatrogenic extrapyramidal symptoms. Cell Mol Neurobiol 2001 21 : 705 16.
34. Cordeiro Q Jr., Elkis H. Pancreatitis and cholestatic hepatitis induced by risperidone. J Clin Psychopharmacol 2001 21 : 529 30.
35. Munyon WH, Salo R, Briones DF. Cytotoxic effects of neuroleptic drugs. Psychopharmacology 1987 91 : 182 88.
36. Hacimuftuoglu A, Aydin N, Halici Z, Demircan B, Sahin O, Bakan E. Chronic treatment of haloperidol decrease antioxidant activity and may cause hepatotoxicity, dose dependently. Eur Neuropsychopharmacol 2005 15 : 521.
37. Pillai A, Parikh V, Terry Jr. AV, Mahadik SB. Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 2007 41 : 372 86.
38. Halici Z, Ozabacigil F, Aydin N, Gulaboglu M, Gul M, Suleyman H. The effects of risperidone, olanzapine and haloperidol on enzyme activities in erythrocytes and plasma of rats. Eur Neuropsychopharmacol 2006 16 (Suppl 4 247 48.
39. Esposito D, Brocvielle H, Becquemont L, Hardy P, Chouinard G, Corruble E. Risperidone-induced immunoallergic hepatitis. Am J Psychiatry 2005 162 : 1984.
40. Pae CU, Lim HK, Kim TS et al. Naturalistic observation on the hepatic enzyme changes in patients treated with either risperidone or olanzapine alone. Int Clin Psychopharmacol 2005 20 : 173 76.
41. Szigethy E, Wiznitzer M, Branicky LA, Maxwell K, Findling RL. Risperidone-induced hepatotoxicity in children and adolescents? A chart review study. J Child Adolesc Psychopharmacol 1999 9 : 93 8.
42. Geller WK, Zuiderwijk PBM, Risperidone-induced hepatotoxicity? J Am Acad Child Adolesc Psychiatry 1998 37 : 246 7.
43. Hummer M, Kurz M, Kurzthaler I, Oberbauer H, Miller C, Fleischhacker WW. Hepatotoxicity of clozapine. J Clin Psychopharmacol 1997 17 : 314 7.